Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Non Operating Income (2016 - 2025)

Jaguar Health (JAGX) has disclosed Non Operating Income for 11 consecutive years, with -$297000.0 as the latest value for Q4 2025.

  • Quarterly Non Operating Income fell 178.57% to -$297000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $43000.0 through Dec 2025, down 15.69% year-over-year, with the annual reading at $43000.0 for FY2025, 15.69% down from the prior year.
  • Non Operating Income for Q4 2025 was -$297000.0 at Jaguar Health, down from -$94000.0 in the prior quarter.
  • The five-year high for Non Operating Income was $1.4 million in Q4 2022, with the low at -$1.1 million in Q2 2022.
  • Average Non Operating Income over 5 years is $23400.0, with a median of -$1000.0 recorded in 2021.
  • Peak annual rise in Non Operating Income hit 8220.0% in 2022, while the deepest fall reached 6276.47% in 2022.
  • Over 5 years, Non Operating Income stood at -$749000.0 in 2021, then surged by 281.58% to $1.4 million in 2022, then crashed by 81.18% to $256000.0 in 2023, then soared by 47.66% to $378000.0 in 2024, then plummeted by 178.57% to -$297000.0 in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at -$297000.0, -$94000.0, and $322000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.